Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein…

Overview of attention for article published in Breast Cancer Research, September 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 80 Mendeley

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATIONS

Application EP-4069225-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.